Foundation One is a genetic test capable of precisely identifying all cells and genes in the genetic profile of patients with solid tumors. Based on its results, physicians gain access to more accurate information, enabling them to adopt a personalized treatment approach for the patient.
Lung cancer was the most diagnosed cancer globally in 2022, with nearly 2.5 million new cases and over 1.8 million deaths.
Consider this test in the following cases:
The methodology used for this test is as follows:
Biopsy: Paraffin Block or Slide
Up to 25 calendar days
Medical request, pathology report
Type | Description |
Technique | NGS + CNVs |
Accuracy | 99% |
Main Office Rua Bento Gonçalves, 59, Room 802 — Centro, Marau, RS — 99150-000
Porto Alegre Office Rua Gomes Jardim, 301 , Room 918/909 — Santana, Porto Alegre, RS — 90620-130